SH2B1 and cancer: Not surprisingly, in cancer cells activation of RET oncogenic signaling, which can be induced and enhanced by SH2B1, can override growth suppressor (RET inhibitors) activities and stimulate cell cycle progression and further potentiates the neoplastic transformation [9].